Skip to main content
NCBI home page
The American Journal of Pathology logoLink to The American Journal of Pathology
. 1995 Oct;147(4):1081–1096.

Transforming growth factor-alpha promotes mammary tumorigenesis through selective survival and growth of secretory epithelial cells.

G H Smith 1, R Sharp 1, E C Kordon 1, C Jhappan 1, G Merlino 1
PMCID: PMC1871019  PMID: 7573353

Abstract

Transforming growth factor (TGF)-alpha stimulates the growth and development of mammary epithelial cells and is implicated in the pathogenesis of human breast cancer. In this report we evaluate the consequences of overexpressing TGF-alpha in the mammary gland of transgenic mice and examine associated cellular mechanisms. When operating on a FVB/N genetic background (line MT100), TGF-alpha induced the stochastic development of mammary adenomas and adenocarcinomas f secretory epithelial origin in 64% of multiparous females. In contrast, tumors were exceedingly rare in virgin MT100 females, MT100 males, and multiparous FVB/N females. In MT100 females multiple foci of hyperplastic secretory lesions preceded the development of frank tumors; these initial lesions appeared during the involution period after the first lactation. Serial transplantation of these hyperplasias indicated an absence of proliferative immortality. Nevertheless, they gave rise to tumors at a low frequency and after a prolonged latency in virgin hosts; in multiparous hosts, tumors developed earlier and at a high incidence. The TGF-alpha transgene was highly expressed in hyperplasias and tumors but not in virgin and nonlesion-bearing tissue, suggesting that TGF-alpha overexpression provides a selective growth advantage. TGF-alpha also induced at lactation a 6.4-fold increase in DNA synthesis in MT100 epithelial cells, many of which were binucleated. MT100 mammary tissue experienced an obvious delay in involution, resulting in the postlactational survival of a significant population of unregressed secretory epithelial cells. In contrast, another line of transgenic mice on a CD-1 genetic background (MT42), in which TGF-alpha overexpression induced liver but not mammary tumors, failed to demonstrate postlactational epithelial cell survival. These data show that TGF-alpha promotes mammary tumorigenesis in multiparous MT100 mice by stimulating secretory epithelial cell proliferation during lactation and prolonging survival during involution. These points support the notion that TGF-alpha can act as a mitogen and also as a differentiation factor in mammary epithelium.

Full text

PDF
1081

Images in this article

1085Figure 1
on p.1085
1086Figure 2
on p.1086
1087Figure 3
on p.1087
1088Figure 4
on p.1088
1089Figure 5
on p.1089
1090Figure 6
on p.1090
1091Figure 7
on p.1091
1092Figure 8
on p.1092
1093Figure 9
on p.1093

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aaronson S. A. Growth factors and cancer. Science. 1991 Nov 22;254(5035):1146–1153. doi: 10.1126/science.1659742. [DOI] [PubMed] [Google Scholar]
  2. Amundadottir L. T., Johnson M. D., Merlino G., Smith G. H., Dickson R. B. Synergistic interaction of transforming growth factor alpha and c-myc in mouse mammary and salivary gland tumorigenesis. Cell Growth Differ. 1995 Jun;6(6):737–748. [PubMed] [Google Scholar]
  3. Arteaga C. L., Hanauske A. R., Clark G. M., Osborne C. K., Hazarika P., Pardue R. L., Tio F., Von Hoff D. D. Immunoreactive alpha transforming growth factor activity in effusions from cancer patients as a marker of tumor burden and patient prognosis. Cancer Res. 1988 Sep 1;48(17):5023–5028. [PubMed] [Google Scholar]
  4. Bates S. E., Davidson N. E., Valverius E. M., Freter C. E., Dickson R. B., Tam J. P., Kudlow J. E., Lippman M. E., Salomon D. S. Expression of transforming growth factor alpha and its messenger ribonucleic acid in human breast cancer: its regulation by estrogen and its possible functional significance. Mol Endocrinol. 1988 Jun;2(6):543–555. doi: 10.1210/mend-2-6-543. [DOI] [PubMed] [Google Scholar]
  5. Bates S. E., Valverius E. M., Ennis B. W., Bronzert D. A., Sheridan J. P., Stampfer M. R., Mendelsohn J., Lippman M. E., Dickson R. B. Expression of the transforming growth factor-alpha/epidermal growth factor receptor pathway in normal human breast epithelial cells. Endocrinology. 1990 Jan;126(1):596–607. doi: 10.1210/endo-126-1-596. [DOI] [PubMed] [Google Scholar]
  6. Bockman D. E., Merlino G. Cytological changes in the pancreas of transgenic mice overexpressing transforming growth factor alpha. Gastroenterology. 1992 Dec;103(6):1883–1892. doi: 10.1016/0016-5085(92)91448-d. [DOI] [PubMed] [Google Scholar]
  7. Bockman D. E., Sharp R., Merlino G. Regulation of terminal differentiation of zymogenic cells by transforming growth factor alpha in transgenic mice. Gastroenterology. 1995 Feb;108(2):447–454. doi: 10.1016/0016-5085(95)90073-x. [DOI] [PubMed] [Google Scholar]
  8. Cardiff R. D., Fanning T. G., Morris D. W., Ashley R. L., Faulkin L. J. Restriction endonuclease studies of hyperplastic outgrowth lines from BALB/cfC3H mouse hyperplastic mammary nodules. Cancer Res. 1981 Aug;41(8):3024–3029. [PubMed] [Google Scholar]
  9. Carpenter G. Receptors for epidermal growth factor and other polypeptide mitogens. Annu Rev Biochem. 1987;56:881–914. doi: 10.1146/annurev.bi.56.070187.004313. [DOI] [PubMed] [Google Scholar]
  10. Daniel C. W., De Ome K. B., Young J. T., Blair P. B., Faulkin L. J., Jr The in vivo life span of normal and preneoplastic mouse mammary glands: a serial transplantation study. Proc Natl Acad Sci U S A. 1968 Sep;61(1):53–60. doi: 10.1073/pnas.61.1.53. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Fowler K. J., Walker F., Alexander W., Hibbs M. L., Nice E. C., Bohmer R. M., Mann G. B., Thumwood C., Maglitto R., Danks J. A. A mutation in the epidermal growth factor receptor in waved-2 mice has a profound effect on receptor biochemistry that results in impaired lactation. Proc Natl Acad Sci U S A. 1995 Feb 28;92(5):1465–1469. doi: 10.1073/pnas.92.5.1465. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Gerschenson L. E., Rotello R. J. Apoptosis: a different type of cell death. FASEB J. 1992 Apr;6(7):2450–2455. doi: 10.1096/fasebj.6.7.1563596. [DOI] [PubMed] [Google Scholar]
  13. Goustin A. S., Leof E. B., Shipley G. D., Moses H. L. Growth factors and cancer. Cancer Res. 1986 Mar;46(3):1015–1029. [PubMed] [Google Scholar]
  14. Halter S. A., Dempsey P., Matsui Y., Stokes M. K., Graves-Deal R., Hogan B. L., Coffey R. J. Distinctive patterns of hyperplasia in transgenic mice with mouse mammary tumor virus transforming growth factor-alpha. Characterization of mammary gland and skin proliferations. Am J Pathol. 1992 May;140(5):1131–1146. [PMC free article] [PubMed] [Google Scholar]
  15. Kerr J. F., Winterford C. M., Harmon B. V. Apoptosis. Its significance in cancer and cancer therapy. Cancer. 1994 Apr 15;73(8):2013–2026. doi: 10.1002/1097-0142(19940415)73:8<2013::aid-cncr2820730802>3.0.co;2-j. [DOI] [PubMed] [Google Scholar]
  16. Kordon E. C., McKnight R. A., Jhappan C., Hennighausen L., Merlino G., Smith G. H. Ectopic TGF beta 1 expression in the secretory mammary epithelium induces early senescence of the epithelial stem cell population. Dev Biol. 1995 Mar;168(1):47–61. doi: 10.1006/dbio.1995.1060. [DOI] [PubMed] [Google Scholar]
  17. Macias A., Perez R., Hägerström T., Skoog L. Identification of transforming growth factor alpha in human primary breast carcinomas. Anticancer Res. 1987 Nov-Dec;7(6):1271–1275. [PubMed] [Google Scholar]
  18. Macias A., Perez R., Hägerström T., Skoog L. Transforming growth factor alpha in human mammary carcinomas and their metastases. Anticancer Res. 1989 Jan-Feb;9(1):177–179. [PubMed] [Google Scholar]
  19. Marchetti A., Buttitta F., Miyazaki S., Gallahan D., Smith G. H., Callahan R. Int-6, a highly conserved, widely expressed gene, is mutated by mouse mammary tumor virus in mammary preneoplasia. J Virol. 1995 Mar;69(3):1932–1938. doi: 10.1128/jvi.69.3.1932-1938.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Marchetti A., Robbins J., Campbell G., Buttitta F., Squartini F., Bistocchi M., Callahan R. Host genetic background effect on the frequency of mouse mammary tumor virus-induced rearrangements of the int-1 and int-2 loci in mouse mammary tumors. J Virol. 1991 Aug;65(8):4550–4554. doi: 10.1128/jvi.65.8.4550-4554.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Matsui Y., Halter S. A., Holt J. T., Hogan B. L., Coffey R. J. Development of mammary hyperplasia and neoplasia in MMTV-TGF alpha transgenic mice. Cell. 1990 Jun 15;61(6):1147–1155. doi: 10.1016/0092-8674(90)90077-r. [DOI] [PubMed] [Google Scholar]
  22. Mizuno M., Yamamoto K., Sakamoto S., Mori T., Harigaya T., Nagasawa H. Normal and neoplastic mammary gland growth in MMTV/TGF alpha transgenic mice. In Vivo. 1994 May-Jun;8(3):263–270. [PubMed] [Google Scholar]
  23. Normanno N., Ciardiello F., Brandt R., Salomon D. S. Epidermal growth factor-related peptides in the pathogenesis of human breast cancer. Breast Cancer Res Treat. 1994 Jan;29(1):11–27. doi: 10.1007/BF00666178. [DOI] [PubMed] [Google Scholar]
  24. Okamoto S., Oka T. Evidence for physiological function of epidermal growth factor: pregestational sialoadenectomy of mice decreases milk production and increases offspring mortality during lactation period. Proc Natl Acad Sci U S A. 1984 Oct;81(19):6059–6063. doi: 10.1073/pnas.81.19.6059. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Perroteau I., Salomon D., DeBortoli M., Kidwell W., Hazarika P., Pardue R., Dedman J., Tam J. Immunological detection and quantitation of alpha transforming growth factors in human breast carcinoma cells. Breast Cancer Res Treat. 1986;7(3):201–210. doi: 10.1007/BF01806251. [DOI] [PubMed] [Google Scholar]
  26. Salomon D. S., Kidwell W. R., Kim N., Ciardiello F., Bates S. E., Valverius E., Lippman M. E., Dickson R. B., Stampfer M. Modulation by estrogen and growth factors of transforming growth factor-alpha and epidermal growth factor receptor expression in normal and malignant human mammary epithelial cells. Recent Results Cancer Res. 1989;113:57–69. doi: 10.1007/978-3-642-83638-1_8. [DOI] [PubMed] [Google Scholar]
  27. Salomon D. S., Kim N., Saeki T., Ciardiello F. Transforming growth factor-alpha: an oncodevelopmental growth factor. Cancer Cells. 1990 Dec;2(12):389–397. [PubMed] [Google Scholar]
  28. Salomon D. S., Zwiebel J. A., Bano M., Losonczy I., Fehnel P., Kidwell W. R. Presence of transforming growth factors in human breast cancer cells. Cancer Res. 1984 Sep;44(9):4069–4077. [PubMed] [Google Scholar]
  29. Sandgren E. P., Luetteke N. C., Palmiter R. D., Brinster R. L., Lee D. C. Overexpression of TGF alpha in transgenic mice: induction of epithelial hyperplasia, pancreatic metaplasia, and carcinoma of the breast. Cell. 1990 Jun 15;61(6):1121–1135. doi: 10.1016/0092-8674(90)90075-p. [DOI] [PubMed] [Google Scholar]
  30. Sell S., Pierce G. B. Maturation arrest of stem cell differentiation is a common pathway for the cellular origin of teratocarcinomas and epithelial cancers. Lab Invest. 1994 Jan;70(1):6–22. [PubMed] [Google Scholar]
  31. Sharp R., Babyatsky M. W., Takagi H., Tågerud S., Wang T. C., Bockman D. E., Brand S. J., Merlino G. Transforming growth factor alpha disrupts the normal program of cellular differentiation in the gastric mucosa of transgenic mice. Development. 1995 Jan;121(1):149–161. doi: 10.1242/dev.121.1.149. [DOI] [PubMed] [Google Scholar]
  32. Silberstein G. B., Daniel C. W. Reversible inhibition of mammary gland growth by transforming growth factor-beta. Science. 1987 Jul 17;237(4812):291–293. doi: 10.1126/science.3474783. [DOI] [PubMed] [Google Scholar]
  33. Smith G. H., Arthur L. A., Medina D. Evidence of separate pathways for viral and chemical carcinogenesis in C3H/StWi mouse mammary glands. Int J Cancer. 1980 Sep 15;26(3):373–379. doi: 10.1002/ijc.2910260318. [DOI] [PubMed] [Google Scholar]
  34. Smith G. H., Medina D. A morphologically distinct candidate for an epithelial stem cell in mouse mammary gland. J Cell Sci. 1988 May;90(Pt 1):173–183. doi: 10.1242/jcs.90.1.173. [DOI] [PubMed] [Google Scholar]
  35. Smith G. H., Teramoto Y. A., Medina D. Hormones, chemicals and proviral gene expression as contributing factors during mammary carcinogenesis in C3H/StWi mice. Int J Cancer. 1981 Jan 15;27(1):81–86. doi: 10.1002/ijc.2910270113. [DOI] [PubMed] [Google Scholar]
  36. Smith G. H., Vonderhaar B. K., Graham D. E., Medina D. Expression of pregnancy-specific genes in preneoplastic mouse mammary tissues from virgin mice. Cancer Res. 1984 Aug;44(8):3426–3437. [PubMed] [Google Scholar]
  37. Strange R., Li F., Saurer S., Burkhardt A., Friis R. R. Apoptotic cell death and tissue remodelling during mouse mammary gland involution. Development. 1992 May;115(1):49–58. doi: 10.1242/dev.115.1.49. [DOI] [PubMed] [Google Scholar]
  38. Suárez-Quian C. A., Niklinski W. Immunocytochemical localization of the epidermal growth factor receptor in mouse testis. Biol Reprod. 1990 Dec;43(6):1087–1097. doi: 10.1095/biolreprod43.6.1087. [DOI] [PubMed] [Google Scholar]
  39. Takagi H., Jhappan C., Sharp R., Merlino G. Hypertrophic gastropathy resembling Ménétrier's disease in transgenic mice overexpressing transforming growth factor alpha in the stomach. J Clin Invest. 1992 Sep;90(3):1161–1167. doi: 10.1172/JCI115936. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Tamano S., Merlino G. T., Ward J. M. Rapid development of hepatic tumors in transforming growth factor alpha transgenic mice associated with increased cell proliferation in precancerous hepatocellular lesions initiated by N-nitrosodiethylamine and promoted by phenobarbital. Carcinogenesis. 1994 Sep;15(9):1791–1798. doi: 10.1093/carcin/15.9.1791. [DOI] [PubMed] [Google Scholar]
  41. Tonelli Q. J., Sorof S. Epidermal growth factor requirement for development of cultured mammary gland. Nature. 1980 May 22;285(5762):250–252. doi: 10.1038/285250a0. [DOI] [PubMed] [Google Scholar]
  42. Travers M. T., Barrett-Lee P. J., Berger U., Luqmani Y. A., Gazet J. C., Powles T. J., Coombes R. C. Growth factor expression in normal, benign, and malignant breast tissue. Br Med J (Clin Res Ed) 1988 Jun 11;296(6637):1621–1624. doi: 10.1136/bmj.296.6637.1621. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Valverius E. M., Bates S. E., Stampfer M. R., Clark R., McCormick F., Salomon D. S., Lippman M. E., Dickson R. B. Transforming growth factor alpha production and epidermal growth factor receptor expression in normal and oncogene transformed human mammary epithelial cells. Mol Endocrinol. 1989 Jan;3(1):203–214. doi: 10.1210/mend-3-1-203. [DOI] [PubMed] [Google Scholar]
  44. Vonderhaar B. K. Local effects of EGF, alpha-TGF, and EGF-like growth factors on lobuloalveolar development of the mouse mammary gland in vivo. J Cell Physiol. 1987 Sep;132(3):581–584. doi: 10.1002/jcp.1041320324. [DOI] [PubMed] [Google Scholar]

Articles from The American Journal of Pathology are provided here courtesy of American Society for Investigative Pathology

RESOURCES